Published in Women's Health Weekly, July 17th, 1995
Recently developed serologic assays that use conformationally correct viral proteins as antigen are providing insight into the humoral response of HPV infection.
Bernadete Nonnenmacher et al. used an ELISA to assess antivirion immune responses in a case-control study in Columbia and Spain ("Serologic Response to Human Papillomavirus Type 16 (HPV-16) Virus-Like Particles in HPV-16 DNA-Positive Invasive Cervical Cancer and Cervical Intraepithelial Neoplasia Grade III Patients and Controls...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.